Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesReproductive Health & FertilityAetna preconceptional sex selection Coverage | Ope…
    Ask Trek AI about this page
    CurrentAetnaPolicy 0323

    Preconceptional Sex Selection Techniques

    Customize your policy alerts

    Sign up for Aetna Policy 0323 alerts

    Get alerted when Policy 0323 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs Aetna's coverage stance on preconceptional sex selection techniques (sperm-sorting and related procedures) and applies to members whose benefits are administered by Aetna and providers performing these services.

    Policy Summary
    PayerAetna
    PolicyPreconceptional Sex Selection Techniques
    Policy CodePolicy 0323
    Change TypeNo material change
    Effective DateMar 18, 1999
    Last ReviewApr 28, 2023
    Next Review DateMar 28, 2024
    Key ActionObtain prior authorization when coverage is sought to prevent X-linked disease and verify plan benefits for associated assisted reproductive services.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    75%max reported enrichment
    0323policy number
    1999-03-18effective date
    04/28/2023last review

    Coverage Criteria

    Medically Necessary Indication

    Covered when ALL of the following are met

    Primary medical necessity: Preconceptional sex selection techniques for enriching sperm samples for X spermatozoa are considered medically necessary only when used to prevent the conception and birth of a male child to a woman who is known to be heterozygous for a seriously handicapping X-linked condition (e.g., Lesch-Nyhan disease).

    Example condition provided in policy.

    Aetna considers assisted reproductive techniques such as in‑vitro fertilization (IVF) or intra‑cytoplasmic sperm injection (ICSI) not to be treatment of disease when the sole indication is sex selection and the procedure is not intended to prevent the birth of a child with a seriously handicapping X‑linked genetic defect. Providers should verify member plan benefits for any related infertility services, as coverage for post‑sperm sorting procedures (for example, intra‑uterine insemination, IVF, or gamete intrafallopian transfer) may be limited by the member’s specific plan or state mandate.

    Use of assisted reproductive techniques solely for nonmedical sex selection purposes (for example, family balancing or other personal, social, or cultural reasons) is not considered treatment of disease and is excluded from medical necessity coverage. Requests for sex selection that are not intended to prevent transmission of a serious X‑linked disorder are not supported under this policy.

    Related Procedure and Billing Codes

    Related CPT/HCPCS codesmixed
    58321Artificial insemination; intra-cervical.
    58322Artificial insemination; intra-uterine.
    58974Embryo transfer, intrauterine.
    58976Gamete, zygote, or embryo intrafallopian transfer, any method.
    88182Flow cytometry, cell cycle or DNA analysis.
    88184Flow cytometry, cell surface, cytoplasmic, or nuclear marker, technical component only; first marker.
    88185Each additional marker (List separately in addition to code for first marker).
    88187Flow cytometry, interpretation; 2 to 8 markers.
    881889 to 15 markers.
    8818916 or more markers.
    1–10 of 19
    1/2

    Provider Actions and Documentation Requirements

    Prior Authorization

    Prior Authorization May Be Required

    Preconceptional sex selection techniques and related services may require prior authorization when coverage is sought under medical benefits.

    • Applies to sperm-sorting and other preconceptional procedures described in this policy.
    • Check member's benefit plan for coverage of assisted reproductive technologies (IVF, ICSI) which may be governed by state mandates or plan-specific limits.
    Documentation Required

    Required Clinical Indication and Follow‑Up

    Documentation must demonstrate the clinical indication and that the request is intended to prevent the conception and birth of a male child to a woman known to be heterozygous for a seriously handicapping X-linked condition (for example, Lesch‑Nyhan disease).

    • Genetic counseling and confirmation of carrier status should be included in the record (eg, medical genetics visit, genetic test results).

    Background

    Primary (pre‑fertilization) sex selection involves enrichment of X‑ or Y‑bearing spermatozoa prior to conception using sperm‑sorting methods such as filtration or flow cytometry. Reported enrichment of sorted samples can be as high as 75%, but enrichment does not guarantee fetal sex. These techniques have been proposed to reduce transmission risk of serious sex‑linked genetic disorders; when used for that indication, invasive prenatal diagnostic testing should be offered when medically indicated to confirm fetal sex.

    Definitions

    Primary sex selection — definition (pre-fertilization sperm sorting)
    TermPrimary sex selection
    DefinitionSex selection prior to fertilization using sperm sorting (filtration and/or flow cytometry) to enrich for X- or Y-bearing spermatozoa.
    Reported effectivenessSamples enriched for X- or Y-bearing spermatozoa to levels as great as 75%.
    LimitationEnrichment increases likelihood of male or female offspring but does not guarantee fetal sex; invasive prenatal diagnostic testing should be offered when medically indicated.
    Clinical rationaleProposed to minimize transmission risk of sex-linked genetic disorders in at-risk couples.
    Secondary sex selection — definition (post-conception prenatal diagnosis and selective termination)

    Revision History

    1999-03-18Policy effective (inception)

    Policy became effective (policy inception).

    2023-04-28ReviewLatest

    Policy last reviewed on this date.

    Policy Summary
    PayerAetna
    PolicyPreconceptional Sex Selection Techniques
    Policy CodePolicy 0323
    Change TypeNo material change
    Effective DateMar 18, 1999
    Last ReviewApr 28, 2023
    Next Review DateMar 28, 2024
    Key ActionObtain prior authorization when coverage is sought to prevent X-linked disease and verify plan benefits for associated assisted reproductive services.
    SourceLink
    On This Page
    Coverage CriteriaRelated Procedure and Billing CodesProvider Actions and Documentation RequirementsBackgroundDefinitionsRevision History
  1. When sperm sorting is used, offer invasive prenatal diagnostic procedures as appropriate to confirm fetal sex when medically indicated.
  2. Denial Risk

    Medical Necessity Limitation — Non‑qualifying Indications Are Not Covered

    Requests for preconceptional sex selection that are for personal, social, cultural, or family‑balancing reasons — and not to prevent the conception and birth of an affected male child as described above — are not medically necessary and will be denied.

    • Provider documentation indicating non‑medical reasons for the request may result in denial.
    • Assisted reproductive techniques performed solely for sex selection without a qualifying medical indication are not considered treatment of disease.
    Billing Rule

    Provider Billing and Coverage Considerations

    Render provider‑impact highlights from source documentation: ensure that coding for related procedures (eg, sperm isolation, flow cytometry, insemination, IVF/embryo transfer, genetic counseling) accurately reflects the services performed and that benefit coverage for downstream infertility services may be limited by the member's plan.

    • Verify applicable CPT/HCPCS codes (eg, 89261, 88182‑88189 series, 96040, S0265, S4011‑S4042) and submit supporting medical records.
    • Confirm whether the member's plan includes coverage for IVF/ART and related procedures before scheduling services.
    TermSecondary sex selection
    DefinitionConception followed by prenatal diagnosis and potential termination of affected fetuses.
    Clinical rationaleUsed as an approach to avoid birth of offspring affected by detectable, heritable disorders after conception.
    Ethical contextACOG supports sex selection to prevent serious sex-linked genetic diseases but opposes nonmedical uses such as family balancing.
    NotePatients are entitled to information about fetal sex; health professionals may sometimes unwittingly participate in sex selection.